LITTLE KNOWN FACTS ABOUT CONOLIDINE.

These final results, together with a former report displaying that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 assistance the notion of focusing on ACKR3 as a novel solution to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-associated Diseases.Healthful joints permit us to